ASH Announces Top Trainee Abstracts of 2015 Annual Meeting

Get Permission

David A. Williams, MD

The American Society of Hematology (ASH) recognized investigators with the highest-scoring abstracts in the categories of undergraduate student, medical student, graduate student, resident physician, and postdoctoral fellow at the 57th ASH Annual Meeting and Exhibition, December 5–8 in Orlando, Florida.

“It is truly exciting to recognize trainees who are already making notable contributions to hematology research,” said 2015 ASH President David A. Williams, MD, President of Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and Leland Fikes Professor of Pediatrics at Harvard Medical School. “ASH is pleased to honor these talented investigators and looks forward to supporting the next generation of hematologists as they continue to pursue improved treatments and cures for patients with blood diseases.” 

The ASH Outstanding Abstract Achievement Award recipients for 2015 are:

Undergraduate Student

Hannah Rasmussen, Harvard University

Oncostatin M Enhances Hematopoietic Stem Cell Homing and Engraftment (Abstract 31)


Medical Student

Bryan Harris, Fox Chase Cancer Center

Rpl22 Deficiency Predisposes Hematopoietic Stem and Progenitor Cells to Leukemogenesis (Abstract 899)


Graduate Student

Lars Klemm, MSc, University of
California, San Francisco

Exposure to Inflammatory Immune Responses as Driver of Clonal Evolution in Childhood Acute Lymphoblastic Leukemia (Abstract 166)


Resident Physician

Ryan Moy, MD, PhD, University of Pennsylvania Perelman School of

Immunologic Effects of CCR5 Blockade in Graft-Versus-Host Disease Prophylaxis (Abstract 920)


Postdoctoral Fellow

Noboru Asada, MD, PhD, Albert Einstein College of Medicine

Distinct Contributions by Perivascular Niche Cells in Hematopoietic Stem Cell Maintenance (Abstract 661)

Mary Rodes Gibson Memorial Award in Hemostasis and Thrombosis

The Mary Rodes Gibson Memorial Award in Hemostasis and Thrombosis was established to recognize the trainee (undergraduate student, medical student, graduate student, resident physician, or postdoctoral fellow) who is the first author and presenter of the highest-scoring abstract submitted to the ASH Annual Meeting in the field of hemostasis and thrombosis. This annual award honoring excellence in hemostasis and thrombosis is made possible by the Mary Rodes Gibson Hemostasis-Thrombosis Foundation to continue the legacy of Mary Rodes Gibson, who suffered from severe, type 3 von Willebrand disease.

The 2015 recipient is:

Shekhar Kumar, PhD, The Children’s Hospital of Philadelphia

The X-Ray Structure of a Variant of Human Factor V Provides Structural Insights Into the Procofactor Activation Paradox (Abstract 121)

Minority Graduate Student Abstract Achievement Award

Each year, ASH offers merit-based Minority Graduate Student Abstract Achievement Awards to select graduate students to acknowledge the accomplishments of and retain minority graduate students in the field of hematology through exposure to the ASH Annual Meeting.

The 2015 Minority Graduate Student Abstract Achievement Award recipients are: 

Morayo Adebiyi, The University of Texas Medical School at Houston

Sustained Elevation of Adenosine-ADORA2B Signaling Promotes Chronic Pain through Neuro-Immune Interaction in Sickle Cell Disease ­(Abstract 974)

Ian Johnston, University of Pennsylvania Perelman School of Medicine

A Targeted Photochemical Microfluidic Vascular Injury Model for in Vitro Thrombosis Studies: Usage in Heparin-Induced Thrombocytopenia (HIT) (Abstract 212)

Randolph Lyde, University of Pennsylvania Perelman School of Medicine

Towards the Care of Hemophilia A Patients Using Induced Pluripotent Stem Cell (iPSC)-Derived Megakaryocytes (iMks) Expressing Coagulation Factor (F) VIII (Abstract 2266)

Katelyn Melgar, University of Cincinnati College of Medicine

Novel Small Molecule FLT3 Inhibitors for the Treatment of FLT3-ITD AML (Abstract 3690)

Shaneice Mitchell, The Ohio State University College of Medicine

In Vitro and in Vivo Anti-Leukemic Effects of KPT-9274, a Reported PAK4 Allosteric Modulator, in Acute Myeloid Leukemia: Promising Results Justifying Further Development in This Disease (Abstract 2471)

To search for individual abstracts online, please visit ■